ASH News Daily 2017 - Issue 1 - C-30
ASH News Daily
Page C-30
Saturday, December 9, 2017
®
Saturday's Poster Sessions
Session ...................................................... Paper Ranges
100s
101. Red Cells and Erythropoiesis, Structure and Function, Metabolism,
and Survival, Excluding Iron: Poster I............................................................. 919 - 935
102. Regulation of Iron Metabolism: Poster I ......................................................... 936 - 943
112. Thalassemia and Globin Gene Regulation: Poster I ....................................... 944 - 952
113. Hemoglobinopathies, Excluding Thalassemia-Basic and
Translational Science: Poster I ....................................................................... 953 - 968
114. Hemoglobinopathies, Excluding Thalassemia-Clinical: Poster I................... 969 - 991
200s
201. Granulocytes, Monocytes, and Macrophages: Poster I ................................ 992 - 1002
203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including
HIV and Other Infections: Poster I .............................................................. 1003 - 1017
300s
301. Vascular Wall Biology, Endothelial Progenitor Cells, and
Platelet Adhesion, Activation, and Biochemistry: Poster I .......................... 1018 - 1032
311. Disorders of Platelet Number or Function: Poster I .................................... 1033 - 1055
321. Blood Coagulation and Fibrinolytic Factors: Poster I.................................. 1056 - 1070
322. Disorders of Coagulation or Fibrinolysis: Poster I ...................................... 1071 - 1092
331. Pathophysiology of Thrombosis: Poster I ................................................... 1093 - 1103
332. Antithrombotic Therapy: Poster I .................................................................1104 - 1116
400s
401. Basic Science and Clinical Practice in Blood Transfusion: Poster I ............1117 - 1132
500s
501. Hematopoietic Stem and Progenitor Biology: Poster I ................................1133 - 1147
502. Hematopoiesis: Regulation of Gene Transcription, Cytokines,
Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster I..........1148 - 1156
506. Hematopoiesis and Stem Cells: Microenvironment, Cell
Adhesion, and Stromal Stem Cells: Poster I................................................1157 - 1165
508. Bone Marrow Failure: Poster I .....................................................................1166 - 1189
600s
602. Disordered Gene Expression in Hematologic Malignancy,
including Disordered Epigenetic Regulation: Poster I ................................ 1190 - 1210
603. Oncogenes and Tumor Suppressors: Poster I ........................................... 1211 - 1238
604. Molecular Pharmacology and Drug Resistance in
Myeloid Diseases: Poster I ......................................................................... 1239 - 1255
605. Molecular Pharmacology, Drug Resistance-Lymphoid and
Other Diseases: Poster I ............................................................................ 1256 - 1270
612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I ......................... 1271 - 1297
613. Acute Myeloid Leukemia: Clinical Studies: Poster I.................................... 1298 - 1316
614. Acute Lymphoblastic Leukemia: Therapy, excluding
Transplantation: Poster I............................................................................. 1317 - 1331
615. Acute Myeloid Leukemia: Commercially Available Therapy,
excluding Transplantation: Poster I ............................................................ 1332 - 1340
616. Acute Myeloid Leukemia: Novel Therapy, excluding
Transplantation: Poster I............................................................................. 1341 - 1380
617. Acute Myeloid Leukemia: Biology, Cytogenetics, and
Molecular Markers in Diagnosis and Prognosis: Poster I ........................... 1381 - 1429
618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and
Molecular Markers in Diagnosis and Prognosis: Poster I ........................... 1430 - 1449
621. Lymphoma-Genetic/Epigenetic Biology: Poster I ..................................... 1450 - 1469
622. Lymphoma Biology-Non-Genetic Studies: Poster I .................................. 1470 - 1486
623. Mantle Cell, Follicular, and Other Indolent B-Cell
Lymphoma-Clinical Studies: Poster I ....................................................... 1487 - 1508
624. Hodgkin Lymphoma and T/NK Cell Lymphoma-Clinical Studies: Poster I......1509 - 1528
625. Lymphoma: Pre-Clinical-Chemotherapy and Biologic Agents: Poster I ... 1529 - 1542
626. Aggressive Lymphoma (Diffuse Large B-Cell and Other
Aggressive B-Cell Non-Hodgkin Lymphomas)-Results from
Prospective Clinical Trials: Poster I ............................................................ 1543 - 1556
627. Aggressive Lymphoma (Diffuse Large B-Cell and Other
Aggressive B-Cell Non-Hodgkin Lymphomas)-Results
from Retrospective/Observational Studies: Poster I ................................... 1557 - 1580
631. Chronic Myeloid Leukemia: Biology and Pathophysiology,
excluding Therapy: Poster I ........................................................................ 1581 - 1588
632. Chronic Myeloid Leukemia: Therapy: Poster I............................................ 1589 - 1629
634. Myeloproliferative Syndromes: Clinical: Poster I ........................................ 1630 - 1652
635. Myeloproliferative Syndromes: Basic Science: Poster I ............................. 1653 - 1667
636. Myelodysplastic Syndromes-Basic and Translational Studies: Poster I ... 1668 - 1683
637. Myelodysplastic Syndromes-Clinical Studies: Poster I ............................ 1684 - 1707
641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I ............... 1708 - 1729
642. CLL: Therapy, excluding Transplantation: Poster I ..................................... 1730 - 1750
651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I ....... 1751 - 1790
652. Myeloma: Pathophysiology and Pre-Clinical Studies,
excluding Therapy: Poster I ........................................................................ 1791 - 1810
653. Myeloma: Therapy, excluding Transplantation: Poster I ............................. 1811 - 1889
700s
701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster I .......1890 - 1903
703. Adoptive Immunotherapy: Poster I ............................................................. 1904 - 1919
711. Cell Collection and Processing: Poster I..................................................... 1920 - 1929
721. Clinical Allogeneic Transplantation: Conditioning Regimens,
Engraftment, and Acute Transplant Toxicities: Poster I .............................. 1930 - 1969
722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD,
Immune Reconstitution: Poster I ................................................................ 1970 - 1990
723. Clinical Allogeneic and Autologous Transplantation: Late Complications
and Approaches to Disease Recurrence: Poster I...................................... 1991 - 2007
731. Clinical Autologous Transplantation: Results: Poster I ............................... 2008 - 2026
732. Clinical Allogeneic Transplantation: Results: Poster I................................. 2027 - 2055
800s
801. Gene Therapy and Transfer: Poster I ......................................................... 2056 - 2067
802. Chemical Biology and Experimental Therapeutics: Poster I....................... 2068 - 2075
900s
901. Health Services Research-Non-Malignant Conditions: Poster I............... 2076 - 2102
902. Health Services Research-Malignant Conditions: Poster I ...................... 2103 - 2132
903. Outcomes Research-Non-Malignant Conditions: Poster I ....................... 2133 - 2148
904. Outcomes Research-Malignant Conditions: Poster I ............................... 2149 - 2193
Posters will be available for
viewing in Hall A2 of the
Georgia World Congress Center
at the times listed below.
Meeting attendees will have the
opportunity to meet the
abstract authors to discuss their
research and ask questions
during the presentation times
listed. Attendees can also take
advantage of PosterCast, a new
feature that provides audio
narration of posters, recorded
directly by the author. Visit the
poster hall to learn more.
Saturday, December 9
Poster Session I - Viewing:
9:00 a.m. - 7:30 p.m.
Poster Session I - Presentations and
Reception: 5:30 p.m. - 7:30 p.m.
Welcome Reception:
5:30 p.m. - 7:30 p.m.
Table of Contents for the Digital Edition of ASH News Daily 2017 - Issue 1
ASH News Daily 2017 - Issue 1 - A-1
ASH News Daily 2017 - Issue 1 - A-2
ASH News Daily 2017 - Issue 1 - A-3
ASH News Daily 2017 - Issue 1 - A-4
ASH News Daily 2017 - Issue 1 - A-5
ASH News Daily 2017 - Issue 1 - A-6
ASH News Daily 2017 - Issue 1 - A-7
ASH News Daily 2017 - Issue 1 - A-8
ASH News Daily 2017 - Issue 1 - A-9
ASH News Daily 2017 - Issue 1 - A-10
ASH News Daily 2017 - Issue 1 - A-11
ASH News Daily 2017 - Issue 1 - A-12
ASH News Daily 2017 - Issue 1 - A-13
ASH News Daily 2017 - Issue 1 - A-14
ASH News Daily 2017 - Issue 1 - A-15
ASH News Daily 2017 - Issue 1 - A-16
ASH News Daily 2017 - Issue 1 - A-17
ASH News Daily 2017 - Issue 1 - A-18
ASH News Daily 2017 - Issue 1 - A-19
ASH News Daily 2017 - Issue 1 - A-20
ASH News Daily 2017 - Issue 1 - A-21
ASH News Daily 2017 - Issue 1 - A-22
ASH News Daily 2017 - Issue 1 - A-23
ASH News Daily 2017 - Issue 1 - A-24
ASH News Daily 2017 - Issue 1 - A-25
ASH News Daily 2017 - Issue 1 - A-26
ASH News Daily 2017 - Issue 1 - A-27
ASH News Daily 2017 - Issue 1 - A-28
ASH News Daily 2017 - Issue 1 - B-1
ASH News Daily 2017 - Issue 1 - B-2
ASH News Daily 2017 - Issue 1 - B-3
ASH News Daily 2017 - Issue 1 - B-4
ASH News Daily 2017 - Issue 1 - B-5
ASH News Daily 2017 - Issue 1 - B-6
ASH News Daily 2017 - Issue 1 - B-7
ASH News Daily 2017 - Issue 1 - B-8
ASH News Daily 2017 - Issue 1 - B-9
ASH News Daily 2017 - Issue 1 - B-10
ASH News Daily 2017 - Issue 1 - B-11
ASH News Daily 2017 - Issue 1 - B-12
ASH News Daily 2017 - Issue 1 - B-13
ASH News Daily 2017 - Issue 1 - B-14
ASH News Daily 2017 - Issue 1 - B-15
ASH News Daily 2017 - Issue 1 - B-16
ASH News Daily 2017 - Issue 1 - B-17
ASH News Daily 2017 - Issue 1 - B-18
ASH News Daily 2017 - Issue 1 - B-19
ASH News Daily 2017 - Issue 1 - B-20
ASH News Daily 2017 - Issue 1 - B-21
ASH News Daily 2017 - Issue 1 - B-22
ASH News Daily 2017 - Issue 1 - B-23
ASH News Daily 2017 - Issue 1 - B-24
ASH News Daily 2017 - Issue 1 - B-25
ASH News Daily 2017 - Issue 1 - B-26
ASH News Daily 2017 - Issue 1 - B-27
ASH News Daily 2017 - Issue 1 - B-30
ASH News Daily 2017 - Issue 1 - B-31
ASH News Daily 2017 - Issue 1 - B-32
ASH News Daily 2017 - Issue 1 - B-33
ASH News Daily 2017 - Issue 1 - B-34
ASH News Daily 2017 - Issue 1 - B-35
ASH News Daily 2017 - Issue 1 - B-36
ASH News Daily 2017 - Issue 1 - B-37
ASH News Daily 2017 - Issue 1 - B-38
ASH News Daily 2017 - Issue 1 - B-39
ASH News Daily 2017 - Issue 1 - B-40
ASH News Daily 2017 - Issue 1 - B-41
ASH News Daily 2017 - Issue 1 - B-42
ASH News Daily 2017 - Issue 1 - B-43
ASH News Daily 2017 - Issue 1 - B-44
ASH News Daily 2017 - Issue 1 - B-45
ASH News Daily 2017 - Issue 1 - B-46
ASH News Daily 2017 - Issue 1 - B-47
ASH News Daily 2017 - Issue 1 - B-48
ASH News Daily 2017 - Issue 1 - B-49
ASH News Daily 2017 - Issue 1 - B-50
ASH News Daily 2017 - Issue 1 - B-51
ASH News Daily 2017 - Issue 1 - B-52
ASH News Daily 2017 - Issue 1 - B-53
ASH News Daily 2017 - Issue 1 - B-54
ASH News Daily 2017 - Issue 1 - B-55
ASH News Daily 2017 - Issue 1 - B-56
ASH News Daily 2017 - Issue 1 - C-1
ASH News Daily 2017 - Issue 1 - C-2
ASH News Daily 2017 - Issue 1 - C-3
ASH News Daily 2017 - Issue 1 - C-4
ASH News Daily 2017 - Issue 1 - C-5
ASH News Daily 2017 - Issue 1 - C-6
ASH News Daily 2017 - Issue 1 - C-7
ASH News Daily 2017 - Issue 1 - C-8
ASH News Daily 2017 - Issue 1 - C-9
ASH News Daily 2017 - Issue 1 - C-10
ASH News Daily 2017 - Issue 1 - C-11
ASH News Daily 2017 - Issue 1 - C-12
ASH News Daily 2017 - Issue 1 - C-13
ASH News Daily 2017 - Issue 1 - C-14
ASH News Daily 2017 - Issue 1 - C-15
ASH News Daily 2017 - Issue 1 - C-16
ASH News Daily 2017 - Issue 1 - C-17
ASH News Daily 2017 - Issue 1 - C-18
ASH News Daily 2017 - Issue 1 - C-19
ASH News Daily 2017 - Issue 1 - C-20
ASH News Daily 2017 - Issue 1 - C-21
ASH News Daily 2017 - Issue 1 - C-22
ASH News Daily 2017 - Issue 1 - C-23
ASH News Daily 2017 - Issue 1 - C-24
ASH News Daily 2017 - Issue 1 - C-25
ASH News Daily 2017 - Issue 1 - C-26
ASH News Daily 2017 - Issue 1 - C-27
ASH News Daily 2017 - Issue 1 - C-28
ASH News Daily 2017 - Issue 1 - C-29
ASH News Daily 2017 - Issue 1 - C-30
ASH News Daily 2017 - Issue 1 - C-31
ASH News Daily 2017 - Issue 1 - C-32
https://www.nxtbookmedia.com